Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Incidence of COVID-19 reinfection among Midwestern healthcare employees

View through CrossRef
Abstract Importance Given the overwhelming worldwide rate of infection and the disappointing pace of vaccination, addressing reinfection is critical. Understanding reinfection, including protection longevity after natural infection, will allow us to better know the prospect of herd immunity, which hinges on the assumption that natural infection generates sufficient, protective immunity. The primary aim of this paper is to provide data on SARS-CoV-2 reinfection over a 10-month period. Objective The primary objective of this study is to establish the incidence of reinfection of COVID-19 among healthcare employees who experienced a prior COVID-19 infection. Design This observational cohort study followed a convenience sample of 2,625 participants who experienced a COVID-19 infection for subsequent COVID-19 infection. Setting Healthcare employees were recruited across a large Midwestern healthcare system. Positive PCR test results were administered and recorded by the system-affiliated lab serving Illinois and Wisconsin. Participants Adult healthcare system employees who enrolled in a research study focused on SARS-CoV-2 antibodies (N = 16,357) and had at least one positive PCR test result between March 1, 2020 and January 10, 2021 were included (N = 2,625). Exposure Positive PCR test for SARS-CoV-2 Main Outcome(s) and Measure(s) The primary outcome is incidence of COVID-19 reinfection, defined by current CDC guidelines (i.e. subsequent COVID-19 infection ≥ 90 days from prior infection). COVID-19 recurrence, defined as subsequent COVID-19 infection after prior infection irrespective of time, is also described. Results Of 2,625 participants who experienced at least one COVID-19 infection during the 10-month study period, 156 (5.94%) experienced reinfection and 540 (20.57%) experienced recurrence after prior infection. Median days were 126.50 (105.50-171.00) to reinfection and 31.50 (10.00-72.00) to recurrence. Incidence rate of COVID-19 reinfection was 0.35 cases per 1,000 person-days, with participants working in COVID-clinical and clinical units experiencing 3.77 and 3.57 times, respectively, greater risk of reinfection relative to those working in non-clinical units. Incidence rate of COVID-19 recurrence was 1.47 cases per 1,000 person-days. Conclusions and Relevance This study supports the consensus that COVID-19 reinfection, defined as subsequent infection ≥ 90 days after prior infection, is rare, even among a sample of healthcare workers with frequent exposure.
Title: Incidence of COVID-19 reinfection among Midwestern healthcare employees
Description:
Abstract Importance Given the overwhelming worldwide rate of infection and the disappointing pace of vaccination, addressing reinfection is critical.
Understanding reinfection, including protection longevity after natural infection, will allow us to better know the prospect of herd immunity, which hinges on the assumption that natural infection generates sufficient, protective immunity.
The primary aim of this paper is to provide data on SARS-CoV-2 reinfection over a 10-month period.
Objective The primary objective of this study is to establish the incidence of reinfection of COVID-19 among healthcare employees who experienced a prior COVID-19 infection.
Design This observational cohort study followed a convenience sample of 2,625 participants who experienced a COVID-19 infection for subsequent COVID-19 infection.
Setting Healthcare employees were recruited across a large Midwestern healthcare system.
Positive PCR test results were administered and recorded by the system-affiliated lab serving Illinois and Wisconsin.
Participants Adult healthcare system employees who enrolled in a research study focused on SARS-CoV-2 antibodies (N = 16,357) and had at least one positive PCR test result between March 1, 2020 and January 10, 2021 were included (N = 2,625).
Exposure Positive PCR test for SARS-CoV-2 Main Outcome(s) and Measure(s) The primary outcome is incidence of COVID-19 reinfection, defined by current CDC guidelines (i.
e.
subsequent COVID-19 infection ≥ 90 days from prior infection).
COVID-19 recurrence, defined as subsequent COVID-19 infection after prior infection irrespective of time, is also described.
Results Of 2,625 participants who experienced at least one COVID-19 infection during the 10-month study period, 156 (5.
94%) experienced reinfection and 540 (20.
57%) experienced recurrence after prior infection.
Median days were 126.
50 (105.
50-171.
00) to reinfection and 31.
50 (10.
00-72.
00) to recurrence.
Incidence rate of COVID-19 reinfection was 0.
35 cases per 1,000 person-days, with participants working in COVID-clinical and clinical units experiencing 3.
77 and 3.
57 times, respectively, greater risk of reinfection relative to those working in non-clinical units.
Incidence rate of COVID-19 recurrence was 1.
47 cases per 1,000 person-days.
Conclusions and Relevance This study supports the consensus that COVID-19 reinfection, defined as subsequent infection ≥ 90 days after prior infection, is rare, even among a sample of healthcare workers with frequent exposure.

Related Results

KECEMASAN SAAT PANDEMI COVID 19: LITERATUR REVIEW Hardiyati, Efri Widianti, Taty Hernawaty Departemen Keperawatan Jiwa Poltekkes Kemenkes Mamuju Sulbar, Universitas Pad...
Recurrence Possibility of COVID-19 in India
Recurrence Possibility of COVID-19 in India
Although nationwide lockdown was imposed in India amid COVID-19 outbreak since March 24, 2020, the COVID-19 infection is increasing day-by-day. India became world’s second most aff...
Burden of the Beast
Burden of the Beast
Introduction Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
Objective Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristi...
COVID-19 reinfection in Afghanistan: A descriptive analysis of data from DHIS2, 2022
COVID-19 reinfection in Afghanistan: A descriptive analysis of data from DHIS2, 2022
Background: Despite millions of COVID-19 infections worldwide since the beginning of the pandemic, relatively few confirmed cases of COVID-19 reinfection have been reported. In Afg...
Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Abstract Introduction Telemedicine is the remote delivery of healthcare services using information and communication technologies and has gained global recognition as a solution to...
A systematic review and meta-analysis on the rate of human schistosomiasis reinfection
A systematic review and meta-analysis on the rate of human schistosomiasis reinfection
Abstract Background While praziquantel mass drug administration is currently the most widely used method in the control of huma...

Back to Top